Core Viewpoint - The stock of Roman Co. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from February 11 to February 13, 2026 [1] Company Summary - Roman Co. conducted a self-examination and inquired with its controlling shareholders and actual controllers, confirming that all production and operations are normal [1] - No significant media reports or market rumors were found that could impact the company's stock trading price [1] - The company disclosed that there are no undisclosed major information, including but not limited to major asset restructuring, share issuance, significant transactions, business restructuring, share buybacks, equity incentives, bankruptcy reorganization, or major business cooperation [1] - During the period of abnormal fluctuation, there were no stock trading activities by the company's directors, senior management, controlling shareholders, actual controllers, or their concerted actors [1] Industry Summary - The latest price-to-book ratio of Roman Co. is 6.97 times, significantly higher than the average price-to-book ratio of 2.61 times for the "construction decoration, renovation, and other construction industries," indicating potential market sentiment overheating and irrational speculation risks [1]

Core Viewpoint - The company announced the resignation of independent director Cheng Jinhua, who is stepping down after nearly six years of service [1] Group 1 - Cheng Jinhua has submitted a written resignation report, citing the completion of his term as an independent director [1] - The resignation includes his roles as a member of the Board Audit and Risk Committee and as the convener of the Compensation and Assessment Committee [1]

南财智讯2月13日电，聚辰股份发布2025年度业绩快报，报告期内公司实现营业收入12.21亿元，同比增 长18.73%；归属于上市公司股东的净利润3.63亿元，同比增长25.01%；基本每股收益2.30元，同比增长 25.00%。 ...

南财智讯2月13日电，吉祥航空公告，1月乘客人数为2212.01千人次，同比下降7.15%，货物及邮件数量 为13407.39吨，同比下降6.28%，当月新增定期航线包括长春—无锡—惠州、浦东—汕头、海口—曼谷 廊曼等往返航线。 ...

Core Viewpoint - Dongbai Group's controlling shareholder, Fujian Fengqi Investment Co., Ltd., has recently released a portion of its pledged shares, totaling 57.04 million shares, from pledge agreements with Huafu Securities Co., Ltd., Xiamen Bank Fuzhou Branch, and Industrial Securities Co., Ltd. [1] Summary by Relevant Categories - **Share Pledge Release**: The company announced the release of 57.04 million shares from pledge agreements [1] - **Involved Financial Institutions**: The shares were released from pledges with three financial institutions: Huafu Securities Co., Ltd., Xiamen Bank Fuzhou Branch, and Industrial Securities Co., Ltd. [1] - **Controlling Shareholder**: The controlling shareholder involved in this transaction is Fujian Fengqi Investment Co., Ltd. [1]

南财智讯2月13日电，碧兴物联公告，公司股东丰图汇烝于2025年11月17日至2026年2月13日期间，通过 集中竞价交易方式减持公司股份767,013股，占公司总股本的0.98%。本次减持计划时间区间已届满，减 持计划实施完毕。减持后，丰图汇烝持有公司股份3,825,945股，占公司总股本的4.87%。 ...

南财智讯2月13日电，安徽建工公告，近日公司及所属子公司收到项目中标通知书。其中，S28溧阳至 芜湖高速公路湾沚至三山段特许经营者项目，中标人为安徽建工集团股份有限公司（牵头人）、中马 （安徽）股权投资合伙企业（有限合伙）、安徽建工路港建设集团有限公司、安徽建工集团投资发展有 限公司、安徽建工公路桥梁建设集团有限公司联合体；项目位于芜湖市，内容主要包括投资、融资、勘 察设计、建设、运营管理、养护维修、移交等，采用特许经营模式，估算总投资约47.98亿元；准备期 及建设期42个月，收费期限354个月。 ...

Core Viewpoint - The company announced that its actual controllers and associated parties have completed a share reduction plan, selling a total of 828,912 shares, which represents 0.96% of the company's current total share capital [1] Group 1: Share Reduction Details - The share reduction occurred between November 21, 2025, and February 13, 2026, through centralized bidding [1] - The breakdown of the share reduction includes: - Ge Weiguo reduced 430,693 shares - Dongguan Weihe Investment Management Partnership reduced 328,219 shares - Jiang Yanbo reduced 40,000 shares - Zhao Jianhua reduced 30,000 shares [1] - The share reduction plan has been fully implemented and complies with relevant laws and regulations as well as reduction commitments [1]

南财智讯2月13日电，宝地矿业公告，公司于2026年1月19日购买的交通银行蕴通财富定期型结构性存款 25天（挂钩汇率看涨）产品，金额3000.00万元，已于2026年2月13日到期赎回，本金和收益已及时归还 至公司募集资金专户；本次赎回获得收益2.77万元。公司再以部分闲置募集资金进行现金管理，截至本 公告披露日尚未使用的募集资金现金管理额度为6500.00万元。不会影响募集资金投资项目进度和公司 正常生产经营。 ...

Core Insights - Warner Pharmaceuticals reported a revenue of 1.516 billion yuan for the fiscal year 2025, representing a year-on-year growth of 7.26% [1] - The net profit attributable to shareholders reached 241 million yuan, showing a significant increase of 46.95% compared to the previous year [1] - Basic earnings per share were reported at 1.84 yuan, reflecting a growth of 47.20% year-on-year [1]